Start of three new ICPerMed-related coordination and support actions

03 June 2020 – Through its Framework Programme Horizon 2020, the European Union started funding three actions in support of ICPerMed in 2020. All three actions focus on different aspects of personalised medicine.

IC2PerMed logo Integrating China in the International Consortium for Personalised Medicine (IC2PerMed)
PERMIT Logo Personalised Medicine Trials (PERMIT)
Logo SINO-EU PerMed Cooperation between China and Europe in Personalised Medicine (SINO-EU PerMed)

ICPerMed is looking forward to fruitful interactions with the three new projects!

ICPerMed works in close collaboration with the European Research Area Network for Personalised Medicine (ERA PerMed), several Coordination and Support Actions (CSAs) funded by the European Commission, as well as with an increasing number of associated and related initiatives, research infrastructures and capacities. This so called ICPerMed ‘Family’ has an important role in supporting the research and implementation of personalised medicine in Europe and beyond.